143 related articles for article (PubMed ID: 26820487)
1. Benefits of Using CD45RA and CD28 to Investigate CD8 Subsets in Kidney Transplant Recipients.
Yap M; Tilly G; Giral M; Brouard S; Degauque N
Am J Transplant; 2016 Mar; 16(3):999-1006. PubMed ID: 26820487
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype.
Tomiyama H; Matsuda T; Takiguchi M
J Immunol; 2002 Jun; 168(11):5538-50. PubMed ID: 12023349
[TBL] [Abstract][Full Text] [Related]
3. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.
Romero P; Zippelius A; Kurth I; Pittet MJ; Touvrey C; Iancu EM; Corthesy P; Devevre E; Speiser DE; Rufer N
J Immunol; 2007 Apr; 178(7):4112-9. PubMed ID: 17371966
[TBL] [Abstract][Full Text] [Related]
4. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.
Takata H; Takiguchi M
J Immunol; 2006 Oct; 177(7):4330-40. PubMed ID: 16982867
[TBL] [Abstract][Full Text] [Related]
5. Cartography of gene expression in CD8 single cells: novel CCR7- subsets suggest differentiation independent of CD45RA expression.
Monteiro M; Evaristo C; Legrand A; Nicoletti A; Rocha B
Blood; 2007 Apr; 109(7):2863-70. PubMed ID: 17148588
[TBL] [Abstract][Full Text] [Related]
6. Effector Memory-Expressing CD45RA (TEMRA) CD8
Doan Ngoc TM; Tilly G; Danger R; Bonizec O; Masset C; Guérif P; Bruneau S; Glemain A; Harb J; Cadoux M; Vivet A; Mai HL; Garcia A; Laplaud D; Liblau R; Giral M; Blandin S; Feyeux M; Dubreuil L; Pecqueur C; Cyr M; Ni W; Brouard S; Degauque N; ;
J Am Soc Nephrol; 2022 Dec; 33(12):2211-2231. PubMed ID: 36280286
[TBL] [Abstract][Full Text] [Related]
7. Phenotype and molecular signature of CD8+ T cell subsets in T cell- mediated rejections after kidney transplantation.
Ko EJ; Seo JW; Kim KW; Kim BM; Cho JH; Kim CD; Seok J; Yang CW; Lee SH; Chung BH
PLoS One; 2020; 15(6):e0234323. PubMed ID: 32530943
[TBL] [Abstract][Full Text] [Related]
8. Increased Pretransplant Frequency of CD28
Cortes-Cerisuelo M; Laurie SJ; Mathews DV; Winterberg PD; Larsen CP; Adams AB; Ford ML
Am J Transplant; 2017 Sep; 17(9):2350-2362. PubMed ID: 28502091
[TBL] [Abstract][Full Text] [Related]
9. Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.
Xu H; Samy KP; Guasch A; Mead SI; Ghali A; Mehta A; Stempora L; Kirk AD
Am J Transplant; 2016 Feb; 16(2):550-64. PubMed ID: 26436448
[TBL] [Abstract][Full Text] [Related]
10. Chronic Kidney Failure Provokes the Enrichment of Terminally Differentiated CD8
Leonhard J; Schaier M; Kälble F; Eckstein V; Zeier M; Steinborn A
Front Immunol; 2022; 13():752570. PubMed ID: 35592311
[TBL] [Abstract][Full Text] [Related]
11. Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division.
Hamann D; Kostense S; Wolthers KC; Otto SA; Baars PA; Miedema F; van Lier RA
Int Immunol; 1999 Jul; 11(7):1027-33. PubMed ID: 10383934
[TBL] [Abstract][Full Text] [Related]
12. CD45RA expression on HCMV-specific effector memory CD8+ T cells is associated with the duration and intensity of HCMV replication after transplantation.
Cantisán S; Solana R; Lara R; Rodríguez-Benot A; Vaquero JM; Gutiérrez-Aroca J; Gayoso I; Montejo M; Rivero A; Torre-Cisneros J
Clin Immunol; 2010 Oct; 137(1):81-8. PubMed ID: 20674505
[TBL] [Abstract][Full Text] [Related]
13. Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.
Tsukishiro T; Donnenberg AD; Whiteside TL
Cancer Immunol Immunother; 2003 Oct; 52(10):599-607. PubMed ID: 12827303
[TBL] [Abstract][Full Text] [Related]
14. Age-associated changes in the frequency of naïve, memory and effector CD8+ T cells.
Hong MS; Dan JM; Choi JY; Kang I
Mech Ageing Dev; 2004 Sep; 125(9):615-8. PubMed ID: 15491679
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of the chemokine receptor CCR5 on virus epitope-specific memory and effector CD8+ T cells.
Fukada K; Sobao Y; Tomiyama H; Oka S; Takiguchi M
J Immunol; 2002 Mar; 168(5):2225-32. PubMed ID: 11859109
[TBL] [Abstract][Full Text] [Related]
16. High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation.
Betjes MGH; Litjens NHR
PLoS One; 2020; 15(2):e0228096. PubMed ID: 32023273
[TBL] [Abstract][Full Text] [Related]
17. Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction.
Yap M; Boeffard F; Clave E; Pallier A; Danger R; Giral M; Dantal J; Foucher Y; Guillot-Gueguen C; Toubert A; Soulillou JP; Brouard S; Degauque N
J Am Soc Nephrol; 2014 Aug; 25(8):1856-68. PubMed ID: 24652799
[TBL] [Abstract][Full Text] [Related]
18. Belatacept-Resistant Rejection Is Associated With CD28
Mathews DV; Wakwe WC; Kim SC; Lowe MC; Breeden C; Roberts ME; Farris AB; Strobert EA; Jenkins JB; Larsen CP; Ford ML; Townsend R; Adams AB
Am J Transplant; 2017 Sep; 17(9):2285-2299. PubMed ID: 28502128
[TBL] [Abstract][Full Text] [Related]
19. Alterations in levels of CD28-/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients.
Crucian B; Dunne P; Friedman H; Ragsdale R; Pross S; Widen R
Clin Diagn Lab Immunol; 1995 Mar; 2(2):249-52. PubMed ID: 7697540
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
Pender MP; Csurhes PA; Pfluger CM; Burrows SR
Mult Scler; 2014 Dec; 20(14):1825-32. PubMed ID: 24842963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
